Herbert Kaltner

Herbert Kaltner

Auto-generated profile, based on publicly available information

Herbert Kaltner

Department of Veterinary Sciences, Chair of Biochemistry and Chemistry, Ludwig-Maximilians-Universität, Lena-Christ-Strasse 48, 82152 Martinsried, Planegg, Germany

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
NANisar Ahmad
Nisar Ahmad
HGHans-Joachim Gabius
Hans-Joachim Gabius
SASabine André
Sabine André
HKHerbert Kaltner
Herbert Kaltner
SSSubramanian Sabesan
Subramanian Sabesan
CBC. Fred Brewer
C. Fred Brewer
Galectin-3 is unique among the galectin family of animal lectins in its biological activities and structure. Most members of the galectin family including galectin-1 possess apoptotic activities, whereas galectin-3 possesses anti-apoptotic activity. Galectin-3 is also the only chimera type galectin and consists of a nonlectin N-terminal domain and a C-terminal carbohydrate-binding domain. Recent sedimentation equilibrium and velocity studies show that murine galectin-3 is a monomer in the absence and presence of LacNAc, a monovalent sugar. However, quantitative precipitation studies in the present report indicate that galectin-3 precipitates as a pentamer with a series of divalent pentasaccharides with terminal LacNAc residues. Furthermore, the kinetics of precipitation are fast, on the order of seconds. This indicates that although the majority of galectin-3 in solution is a monomer, a rapid equilibrium exists between the monomer and a small percentage of pentamer. The latter, in turn, precipitates with the divalent oligosaccharides, resulting in rapid conversion of monomer to pentamer by mass action equilibria. Mixed quantitative precipitation experiments and electron microscopy suggest that galectin-3 forms heterogenous, disorganized cross-linking complexes with the multivalent carbohydrates. This contrasts with galectin-1 and many plant lectins that form homogeneous, organized cross-linked complexes. The results are discussed in terms of the biological properties of galectin-3.

1 October 2004 in Journal of Molecular Biology
Verified
Journal Article
Closed access
MLMaría F. López-Lucendo
María F. López-Lucendo
DSDolores Solis
Dolores Solis
SASabine André
Sabine André
JHJun Hirabayashi
Jun Hirabayashi
KKKen-Ichi Kasai
Ken-Ichi Kasai
ARAntonio Romero
Antonio Romero

1 September 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JKJürgen Kopitz
Jürgen Kopitz
CRCarolina von Reitzenstein
Carolina von Reitzenstein
SASabine André
Sabine André
HKHerbert Kaltner
Herbert Kaltner
JUJohannes Uhl
Johannes Uhl
HGHans-Joachim Gabius
Hans-Joachim Gabius
The cell density-dependent growth inhibition of human SK-N-MC neuroblastoma cells is initiated by increased ganglioside sialidase activity leading to elevated cell surface presentation of ganglioside GM1, a ligand of galectin-1. We herein show that the extent of the cell surface expression of the galectin coincides with marked increases of the sialidase activity. Reverse transcriptase-polymerase chain reaction analysis excludes a regulation at the transcriptional level. Exposure of cells to purified galectin-1 reveals its carbohydrate-dependent activity to reduce cell proliferation. Assays to detect DNA fragmentation biochemically and cytometrically and to block caspases render it unlikely that galectin-1 acts as a classical proapoptotic factor on these cells. Because the chimeric galectin-3 shares binding sites and binding parameters with galectin-1 for these cells, we tested whether this galectin will elicit the same response as the homodimeric cross-linking galectin-1. Evidently, galectin-3 fails to affect cell growth by itself but interferes with galectin-1 upon coincubation. Its proteolytically truncated variant, the C-terminal lectin domain with impaired capacity to form aggregates when surface bound, has only weak binding properties. Thus, the way in which the galectin-1 interacts topologically with an apparently common set of ligands relative to galectin-3 is crucial for eliciting post-binding events. We conclude that galectin-1 is a probable effector in the sialidase-dependent growth control in this system. Moreover, the experiments with galectin-3 reveal functional divergence, most probably based on different topologies of presentation of homologous carbohydrate-binding sites.

26 August 2005 in Biochemistry
Verified
Journal Article
Closed access
TDTarun K. Dam
Tarun K. Dam
HGHans-Joachim Gabius
Hans-Joachim Gabius
SASabine André
Sabine André
HKHerbert Kaltner
Herbert Kaltner
MLMartin Lensch
Martin Lensch
CBC. Fred Brewer
C. Fred Brewer

15 September 2004 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
ASAndreas Sturm
Andreas Sturm
MLMartin Lensch
Martin Lensch
SASabine André
Sabine André
HKHerbert Kaltner
Herbert Kaltner
BWBertram Wiedenmann
Bertram Wiedenmann
HGHans-Joachim Gabius
Hans-Joachim Gabius
Galectin-2 is structurally closely related to galectin-1, but has a distinct expression profile primarily confined to the gastrointestinal tract. Prominent differences in the proximal promoter regions between galectins-2 and -1 concern Sp1-, hepatocyte NF-3, and T cell-specific factor-1 binding sites. Of note, these sequence elements are positioned equally in the respective regions for human and rat galectins-2. Labeled galectin-2 binds to T cells in a β-galactoside-specific manner. In contrast to galectin-1, the glycoproteins CD3 and CD7 are not ligands, while the shared affinity to β1 integrin (or a closely associated glycoprotein) accounts for a substantial extent of cell surface binding. The carbohydrate-dependent binding of galectin-2 induces apoptosis in activated T cells. Fluorogenic substrate and inhibitor assays reveal involvement of caspases-3 and -9, in accordance with cleavage of the DNA fragmentation factor. Enhanced cytochrome c release, disruption of the mitochondrial membrane potential, and an increase of the Bax/Bcl-2 ratio by opposite regulation of expression of both proteins add to the evidence that the intrinsic apoptotic pathway is triggered. Cell cycle distribution and expression of regulatory proteins remained unaffected. Notably, galectins-1 and -7 reduce cyclin B1 expression, defining functional differences between the structurally closely related galectins. Cytokine secretion of activated T cells was significantly shifted to the Th2 profile. Our study thus classifies galectin-2 as proapoptotic effector for activated T cells, raising a therapeutic perspective. Of importance for understanding the complex galectin network, it teaches the lesson that selection of cell surface ligands, route of signaling, and effects on regulators of cell cycle progression are markedly different between structurally closely related galectins.

30 October 2001 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
SASabine André
Sabine André
Roland PietersRoland Pieters
Roland Pieters
IVIoannis Vrasidas
Ioannis Vrasidas
HKHerbert Kaltner
Herbert Kaltner
IKIchiro Kuwabara
Ichiro Kuwabara
HGHans-Joachim Gabius
Hans-Joachim Gabius